These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 11734681

  • 21. [Lacrimal film evaluation of patients with facial dystonia during botulinum toxin type A treatment].
    Costa PG, Cardoso IP, Saraiva FP, Raiza AC, Tanaka LK, Matayoshi S.
    Arq Bras Oftalmol; 2006; 69(3):319-22. PubMed ID: 16936952
    [Abstract] [Full Text] [Related]

  • 22. Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation.
    Thussu A, Barman CR, Prabhakar S.
    Neurol India; 1999 Sep; 47(3):206-9. PubMed ID: 10514580
    [Abstract] [Full Text] [Related]

  • 23. Beneficial effects of botulinum toxin type a for patients with painful tic convulsif.
    Micheli F, Scorticati MC, Raina G.
    Clin Neuropharmacol; 2002 Sep; 25(5):260-2. PubMed ID: 12410057
    [Abstract] [Full Text] [Related]

  • 24. Evaluating Headache Incidence and Characteristics After Botulinum Toxin Treatment in Blepharospasm and Hemifacial Spasm Patients: A Retrospective Cohort Clinical Study.
    Bilgin S, Ozdemir KT, Yaka EC, Demir Ö, Aydın H, Şener U.
    Clin Neuropharmacol; 2002 Sep; 47(5):157-162. PubMed ID: 39258549
    [Abstract] [Full Text] [Related]

  • 25. Prevalence of periocular depigmentation after repeated botulinum toxin A injections in African American patients.
    Roehm PC, Perry JD, Girkin CA, Miller NR.
    J Neuroophthalmol; 1999 Mar; 19(1):7-9. PubMed ID: 10098540
    [Abstract] [Full Text] [Related]

  • 26. Botulinum neurotoxin for the treatment of movement disorders.
    Kopanidis P, Das C.
    Aust J Gen Pract; 2018 Sep; 47(9):598-601. PubMed ID: 30244558
    [Abstract] [Full Text] [Related]

  • 27. [Ocular wavefront aberrations in patients with facial dystonia treated with botulinum toxin].
    Yabiku MM, Sartori Jde F, Sarraff EP, Osaki TH, Hossaka SK, Pereira CI, Freitas Wd, Osaki MH, Cariello AJ.
    Arq Bras Oftalmol; 2011 Sep; 74(6):414-6. PubMed ID: 22331113
    [Abstract] [Full Text] [Related]

  • 28. What is new in the era of focal dystonia treatment? Botulinum injections and more.
    Cetinkaya A, Brannan PA.
    Curr Opin Ophthalmol; 2007 Sep; 18(5):424-9. PubMed ID: 17700237
    [Abstract] [Full Text] [Related]

  • 29. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Cakmur R, Ozturk V, Uzunel F, Donmez B, Idiman F.
    J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
    [Abstract] [Full Text] [Related]

  • 30. [Treatment of hemifacial spasm with botulinum A toxin].
    Duzyński W, Sławek J.
    Neurol Neurochir Pol; 1998 Jan; 32 Suppl 1():61-9. PubMed ID: 9608555
    [Abstract] [Full Text] [Related]

  • 31. Botulinum toxin management of upper facial rhytidosis and blepharospasm.
    Seiff SR, Zwick OM.
    Otolaryngol Clin North Am; 2005 Oct; 38(5):887-902. PubMed ID: 16214565
    [No Abstract] [Full Text] [Related]

  • 32. Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study.
    Rollnik JD, Matzke M, Wohlfarth K, Dengler R, Bigalke H.
    Eur Neurol; 2000 Oct; 43(1):9-12. PubMed ID: 10601802
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Long-term efficacy of botulinum a toxin for blepharospasm and hemifacial spasm.
    Gill HS, Kraft SP.
    Can J Neurol Sci; 2010 Sep; 37(5):631-6. PubMed ID: 21059510
    [Abstract] [Full Text] [Related]

  • 38. Headache and facial pain responsive to botulinum toxin: an unusual presentation of blepharospasm.
    Johnstone SJ, Adler CH.
    Headache; 1998 May; 38(5):366-8. PubMed ID: 9630789
    [Abstract] [Full Text] [Related]

  • 39. Outcome of Injection Botulinum Toxin in Blepharospasm.
    Amatya M, Limbu B, Sthapit PR, Gurung HB, Saiju R.
    Nepal J Ophthalmol; 2021 Jan; 13(25):40-49. PubMed ID: 33981096
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.